BI-1808 and pembrolizumab combination shows a 24% ORR in recurrent ovarian cancer, surpassing pembrolizumab monotherapy's 8% ...
The proposed expansion of an open pit coal mine in British Columbia is raising concerns about downstream water pollution in the Columbia River Basin.